Table 4.
Antibiotic Regimen | All | A | B | C | P value, A vs. B |
---|---|---|---|---|---|
No. evaluable courses | 426 | 113 | 274 | 39 | |
No. of courses with bacteremia | 81 | 55* | 22 | 4 | <0.0001 |
No. of identified bacteria | 94 | 59 | 31 | 4 | <0.0001 |
Gram-positive bacteria (n) | |||||
Viridans group streptococci | 37 | 33 (7) | 3 (2) | 1 (1) | 0.001 |
Enterococcus species | 8 | 1 | 7 | 0 | |
Bacillus cereus | 4 | 2 (1) | 2 | 0 | |
Coagulase-negative Staphylococcus | 4 | 0 | 1 | 3 | |
Stomatococcus mucilaginosus | 4 | 3 | 1 | 0 | |
Streptococcus pneumoniae | 1 | 1 | 0 | 0 | |
Abiotrophia defectiva | 1 | 0 | 1 | 0 | |
Lactobacillus rhamnosus/casei | 1 | 0 | 1 | 0 | |
Rothia dentocariosa | 1 | 0 | 1 | 0 | |
Granulicatella adiacens | 1 | 0 | 1 | 0 | |
Total gram-positive (n) | 62 | 40 | 18 | 4 | 0.0003 |
Gram-negative bacteria (n) | |||||
Escherichia coli | 11 | 7 | 4 | 0 | |
Pseudomonas aeruginosa | 7 | 3 | 4 | 0 | |
Enterobacter cloacae | 6 | 4 | 2 | 0 | |
Klebsiella pneumoniae | 3 | 2 | 1 | 0 | |
Neisseria subflava/sicca | 1 | 0 | 1 | 0 | |
Moraxella nonliquefaciens | 1 | 1 | 0 | 0 | |
Burkholderia cepacia | 1 | 1 | 0 | 0 | |
Capnocytophaga sputigena | 1 | 0 | 1 | 0 | |
Sphingomonas species | 1 | 1 | 0 | 0 | |
Total gram-negative (n) | 32 | 19 | 13 | 0 | 0.001 |
One patient had 2 episodes of bacteremia in a course.
Bloodstream infection was defined by Centers for Disease Control and Prevention (CDC) criteria, with the following exception for common commensals: even one positive blood culture was considered to indicate a bloodstream infection with viridans streptococci or Bacillus cereus in patients with grade 3 or 4 neutropenia. These episodes are shown in the parentheses.
A: Either patients received no prophylactic antibiotics or they received only prophylactic oral cephalosporins.
B: Prophylaxis with IV cefepime only or IV vancomycin plus an oral cephalosporin, oral ciprofloxacin, or IV cefepime.
C: Not evaluable.